Reduction in COVID-19-related mortality over time but disparities across population subgroups
Mark W. Tenforde, Ruth Link‐Gelles
Abstract
More than 3 years into the pandemic, the world has made major progress in understanding, preventing, and treating COVID-19, and has experienced periods of substantial individual and societal disruption. High rates of immunity from vaccination and recovery from previous infection are now observed among populations,1 which are likely to attenuate the severity of new infections due to long-lasting cellular and humoral immunity.2 Greater normalcy has returned as governments have ended pandemic restrictions or declared an end to COVID-19 as a public health emergency.
Topics & Concepts
Coronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakMedicineBetacoronavirusPopulationMEDLINEPandemicDemographyVirologyInternal medicineEnvironmental healthDiseaseOutbreakBiologyInfectious disease (medical specialty)SociologyBiochemistryCOVID-19 Clinical Research StudiesCOVID-19 epidemiological studiesCOVID-19 and healthcare impacts